Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Gynecomastia × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1287 Carcinoma, Renal Cell 654 Urinary Bladder Neoplasms 405 Carcinoma, Non-Small-Cell Lung 329 Neoplasms 299 Carcinoma, Transitional Cell 261 Breast Neoplasms 251 Ovarian Neoplasms 246 Melanoma 235 Colorectal Neoplasms 224 Neoplasm Metastasis 212 Kidney Neoplasms 198 Pancreatic Neoplasms 169 Stomach Neoplasms 161 Squamous Cell Carcinoma of Head and Neck 142 Lung Neoplasms 140 Uterine Cervical Neoplasms 122 Non-Muscle Invasive Bladder Neoplasms 117 Head and Neck Neoplasms 111 Triple Negative Breast Neoplasms 110 Endometrial Neoplasms 109 Esophageal Neoplasms 107 Carcinoma, Hepatocellular 96 Small Cell Lung Carcinoma 77 Sarcoma 75 Colonic Neoplasms 55 Urologic Neoplasms 52 Prostatic Neoplasms, Castration-Resistant 47 Liver Neoplasms 47 Carcinoma 43

Interventions

bicalutamide 1 Tamoxifen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00637871 2011-01-24

Casodex - Nolvadex Combination

AstraZeneca

Phase 2 Completed

Gynecomastia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡